Renal thrombotic microangiopathy in systemic lupus erythematosus: Clinical correlations and long-term renal survival

被引:40
|
作者
Bridoux, F
Vrtovsnik, F
Noel, C
Saunier, P
Mougenot, B
Lemaitre, V
Dracon, M
Lelievre, G
Vanhille, P
机构
[1] Dept Nephrol, Valenciennes, France
[2] Dept Nephrol, Lille, France
[3] Hop Tenon, Dept Pathol, F-75970 Paris, France
关键词
systemic lupus erythematosus; thrombotic microangiopathy; acute renal failure; antiphospholipid antibodies; renal biopsy;
D O I
10.1093/oxfordjournals.ndt.a027822
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Renal (TMA) is an uncommon vascular complication of systemic lupus erythematosus (SLE). Its clinical symptoms and impact on renal survival remain unclear. Methods. Eight patients aged 25 +/- 6 years with biopsy-proven renal TMA and at least four ARA criteria for the diagnosis of SLE were retrospectively studied over a 7-year period. Results. All patients presented with renal failure (creatinine 3.3 +/- 2.1 mg/dl), six had proteinuria (2.5 +/- 1.3 g/day) with microscopic haematuria in four cases. Six patients had hypertension, which was severe in five cases. Renal histology disclosed arterial and/or arteriolar thrombosis with parietal thickening without angeitis (8 patients), glomerular microthrombi (3 patients), and vascular fibrin deposits (5/6 patients). In two cases, vascular lesions were associated with a mesangial or a proliferative glomerulonephritis. Thrombocytopenia was present in four patients with haemolytic microangiopathic anaemia in one case. Lupus anticoagulant (LA) was detected in five of eight patients, who also had anticardiolipin antibodies (3/7 patients) and/or were positive for VDRL (3/6 patients). Four patients with LA experienced arterial thrombosis and/or repeated spontaneous abortions. Treatment consisted of corticosteroids (8 patients), cytotoxic drugs (4 patients), plasma exchanges and/or intravenous immunoglobulins (4 patients) and antiplatelet and/or anticoagulant therapy (3 patients). Two patients recovered normal renal function and five had persistent renal insufficiency. One patient started haemodialysis on admission and died of sepsis 2 months later. Conclusions. TMA may be the sole renal complication in SLE and is not usually associated with haemolytic microangiopathic anaemia. In our series renal survival was influenced by the extent and severity of vascular lesions. Despite a frequent association with antiphospholipid antibodies, pathophysiological mechanisms of renal TMA in SLE remain unknown. Renal histology is mandatory for the diagnosis and the prognostic evaluation of renal vasculopathy in SLE.
引用
收藏
页码:298 / 304
页数:7
相关论文
共 50 条
  • [21] Serial renal biopsy in systemic lupus erythematosus
    Bajaj, S
    Albert, L
    Gladman, DD
    Urowitz, MB
    Hallett, DC
    Ritchie, S
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (12) : 2822 - 2826
  • [22] Renal infarction in a child with systemic lupus erythematosus
    Kuzmanovska, DB
    Sahpazova, EM
    Grujovska, SJ
    Trajkovski, Z
    PEDIATRIC NEPHROLOGY, 2004, 19 (06) : 685 - 687
  • [23] Renal infarction in a child with systemic lupus erythematosus
    Dafina B. Kuzmanovska
    Emilija M. Sahpazova
    Stevka J. Grujovska
    Zoran Trajkovski
    Pediatric Nephrology, 2004, 19 : 685 - 687
  • [24] Thrombotic microangiopathy in a patient with systemic lupus erythematosus and anti-factor H autoantibodies
    Cátia Raquel Figueiredo
    Rachele Escoli
    Paulo Santos
    Flora Sofia
    Karina Lopes
    CEN Case Reports, 2022, 11 : 26 - 30
  • [25] ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus
    Parodis, Ioannis
    Gokaraju, Sirisha
    Zickert, Agneta
    Vanarsa, Kamala
    Zhang, Ting
    Habazi, Deena
    Botto, Joao
    Alves, Clara Serdoura
    Giannopoulos, Panagiotis
    Larsson, Anders
    Svenungsson, Elisabet
    Gunnarsson, Iva
    Mohan, Chandra
    RHEUMATOLOGY, 2020, 59 (09) : 2237 - 2249
  • [26] Renal and systemic amyloidosis in systemic lupus erythematosus
    Singh, NP
    Prakash, A
    Sridhara, G
    Dinda, AK
    Agarwal, SK
    RENAL FAILURE, 2003, 25 (04) : 671 - 675
  • [27] Thrombotic microangiopathy in a patient with systemic lupus erythematosus and anti-factor H autoantibodies
    Figueiredo, Catia Raquel
    Escoli, Rachele
    Santos, Paulo
    Sofia, Flora
    Lopes, Karina
    CEN CASE REPORTS, 2022, 11 (01) : 26 - 30
  • [28] Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus
    Yafasova, Adelina
    Fosbol, Emil L.
    Schou, Morten
    Baslund, Bo
    Faurschou, Mikkel
    Docherty, Kieran F.
    Jhund, Pardeep S.
    McMurray, John J. V.
    Sun, Guoli
    Kristensen, Soren L.
    Torp-Pedersen, Christian
    Kober, Lars
    Butt, Jawad H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 77 (14) : 1717 - 1727
  • [29] Acute renal failure, systemic lupus erythematosus and thrombotic microangiopathy following treatment with beta-interferon for multiple sclerosis: case report and review of the literature
    Hansen, Thomas
    New, David
    Reeve, Roy
    Donne, Rosemary
    Stephens, William
    CLINICAL KIDNEY JOURNAL, 2009, 2 (06): : 466 - 468
  • [30] Paraneoplastic pemphigus:: A case of long-term survival associated with systemic lupus erythematosus and polymyositis
    Mascaro, JM
    Ferrando, J
    Solé, MT
    Alsina, M
    Nousari, HC
    Anhalt, GJ
    Font, J
    Mascaró, JM
    DERMATOLOGY, 1999, 199 (01) : 63 - 66